Skip to content
Open access

Clinical Outcomes in Pediatric COVID‐19 Across Two Time Periods: The Role of Coinfection, Age, and Inflammatory Markers

Sep 2026 · Journal of Medical Virology · Vol 98 · 0 citations · 47 references
Medicine

TL;DR

Pediatric COVID‐19 outcomes appear to be mostly influenced by coinfections, lower respiratory tract involvement, and younger age, with newborns being the most vulnerable group.

Abstract

The COVID‐19 pandemic is a widespread condition caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). This study examines the shifting epidemiology, risk factors for severe disease, and treatment approaches in pediatric SARS‐CoV‐2 infection. In this retrospective, single‐center study, 275 children (aged 0–18 years) with confirmed SARS‐CoV‐2 infection (December 2023–December 2025) were analyzed. Demographic, clinical, laboratory, and microbiological data were collected. Of 275 patients, 40.0% were in Period 1 and 60.0% in Period 2. The overall hospitalization rate was 25.1%. Coinfection (17.8%) emerged as a key determinant of severity, being associated with higher hospitalization (40.8% vs. 21.7%) and PICU admission (12.2% vs. 3.5%). Lower respiratory tract involvement was the strongest clinical predictor of severe disease, with markedly increased hospitalization (51.1% vs. 18.3%) and PICU/intubation rates (22.2% vs. 2.0%). Infants (< 1 year) represented the highest‐risk group across all severity indicators. Antibiotics were used in 45.5% of patients, but only 28.0% had a documented bacterial co‐pathogen. Antibiotic use was associated with higher rates of hospitalization and PICU admission. Infants < 1 year showed the highest rates of hospitalization, PICU admission, pneumonia, and coinfection. Pediatric COVID‐19 outcomes appear to be mostly influenced by coinfections, lower respiratory tract involvement, and younger age, with newborns being the most vulnerable group. The widespread use of empirical antibiotics emphasizes the need for more cautious and reasonable antimicrobial stewardship. Integrating readily available clinical findings with specific laboratory markers may enable earlier and more precise risk categorization, ultimately guiding tailored and effective treatment in children.

Read PDF

Similar papers

Open access Sep 2026

Risk Factors of COVID-19 Severity and Related Death in Children in the Post-Pandemic Era

In the post-pandemic era, identifying children who are most susceptible to severe illness and COVID-19-related mortality is essential for guiding public health policies. This study examined the risk factors for COVID-19-related severe illness and mortality from 2023 to mid-2025. We conducted a population-based cohort s...

Laura G. Coelho, Lilian M. Diniz, Stella C. Galante et al. · 0 citations

Clinical and Laboratory Predictors of Disease Severity in Hospitalized Children with COVID-19: A Study from the Early Pandemic Period

The aim of this manuscript is to evaluate the clinical, laboratory, and radiological characteristics of hospitalized children with COVID-19 and to compare findings according to disease severity, to understand risk factors associated with severe disease, particularly in upper-middle-income healthcare settings.

A. Boğa, Elif Betül, Keskin Çetinkaya et al. · 0 citations
Open access Sep 2026

SARS-CoV-2 Coinfections and Severity in Hospitalized Children With Systematic Testing.

Differences observed when including centers without systematic testing underscore the importance of considering testing strategies when evaluating the clinical impact of coinfections, and SARS-CoV-2 respiratory viral coinfections were not associated with increased COVID-19 severity.

C. di Chiara, Daniel S. Farrar, J. Bettinger et al. · 0 citations
Open access Sep 2026

Short- and long-term impact of SARS-CoV-2 on clinical characteristics of Graves’ disease patients: a retrospective cohort study

Background The aim of this study was to comprehensively evaluate the effects of SARS-CoV-2 infection on treated Graves’ disease (GD) patients. Methods This single-center retrospective cohort study included 220 patients with GD receiving stable antithyroid drug treatment. Among 179 questionnaire respondents, 107 had con...

Bingxin Li, Shi-Qi Song, Yu-Wei Gong et al. · 0 citations
Open access Aug 2026

Typical and Atypical Clinics in COVID-19 (SARS-Cov-2) RT-PCR Positive Patients: A Multicenter Retrospective Study

In this study, we sought to determine the consistency of symptoms in patients admitted to three high-volume emergency departments with a diagnosis of COVID-19 with the standard definition published by the Turkish Ministry of Health, and to examine the relationship between symptom type and clinical outcomes. This multic...

R. Alagöz, N. Acar, E. Karakilic et al. · 0 citations
Open access 2026

PROFILING COMORBIDITIES IN COVID-19 PATIENTS: RETROSPECTIVE EVIDENCE FROM THE PANDEMIC…

Objectives. This retrospective study aims to characterize demographics, comorbidities, clinical-laboratory features and outcomes of COVID-19 patients admitted to the Infectious Diseases Service during the 2020 pandemic period. Material and methods. A total of 1001 patients with confirmed COVID-19 (via RT-PCR) admitted...

Esi Duka, N. Çomo, E. Petrela · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.